retatrutide triple hormone receptor agonist benefits THE EFFECT OF TRIPLE-HORMONE-RECEPTOR RETATRUTIDE, A NOVEL MEDICATION FOR WEIGHT LOSS, ON BLOOD PRESSURE - A META-ANALYSIS OF RANDOMIZED CONTROLLED PHASE 2 TRIALS Retatrutide: Understanding Its Triple Receptor

In an interview with HCPLive, Mark Taylor, MD, consultant psychiatrist at The Edinburgh Practice and professor at Griffith University, discussed a Swedish registry study that compared periods when patients were on GLP-1 therapy versus off treatment, effectively using each patient as their own control

Despite GK being first reported more than 50 years ago and subsequent extensive research efforts , a GKA is yet to be approved

Close monitoring of glucose concentrations after initiation and throughout therapy with pasireotide treatment is mandatory (8, 24)

Background care (concomitant use of statins, angiotensin converting enzyme inhibitors /angiotensin receptor blockers, beta-blockers and dual antiplatelet therapy) may also play a role in this discrepancy